| NOTE 10 |
– |
BASIC
LOSS PER SHARE |
The
basic and diluted net loss per share and weighted average number of shares of Common Stock used in the calculation of basic and
diluted net loss per share are as follows (USD in thousands, except share and per share data):
| |
|
Six months ended June 30,
|
|
| |
|
2020 |
|
|
2019 |
|
| |
|
|
|
|
|
|
| Net loss |
|
|
12,107 |
|
|
|
7,003 |
|
| Interest accrued on preferred shares (pre-merger – BiomX Israel) |
|
|
- |
|
|
|
2,381 |
|
| Net loss used in the calculation of basic net loss per share |
|
|
12,107 |
|
|
|
9,384 |
|
| Net loss per share |
|
|
0.53 |
|
|
|
4.68 |
|
| Weighted average number of shares of Common Stock |
|
|
22,944,482 |
|
|
|
2,005,047 |
|
| |
|
Three months ended June 30,
|
|
| |
|
2020 |
|
|
2019 |
|
| |
|
|
|
|
|
|
| Net loss |
|
|
6,206 |
|
|
|
3,778 |
|
| Interest accrued on preferred shares (pre-merger – BiomX Israel) |
|
|
- |
|
|
|
1,231 |
|
| Net loss used in the calculation of basic net loss per share |
|
|
6,206 |
|
|
|
5,009 |
|
| Net loss per share |
|
|
0.27 |
|
|
|
2.50 |
|
| Weighted average number of shares of Common Stock |
|
|
22,944,482 |
|
|
|
2,005,047 |
|
|